• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alpine Immune Sciences, Inc. - Common Stock (NQ:ALPN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 64.33 (1)
Ask (Size) 65.64 (1)
Prev. Close 64.97
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 23,914,879
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences ↗
May 16, 2024
 
Via Benzinga
News headline image
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q1 2024 ↗
May 09, 2024
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

More News

Read More
News headline image
Alpine Immune Sciences Reports First Quarter 2024 Financial Results
May 09, 2024
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗
May 03, 2024
Via InvestorPlace
News headline image
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72 ↗
May 01, 2024
Via Investor's Business Daily
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 4/16
April 16, 2024
Via Investor Brand Network
News headline image
Sarepta Therapeutics Stock Shows Improved Technical Strength ↗
April 29, 2024
Via Investor's Business Daily
News headline image
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
April 26, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs ↗
April 26, 2024
Via Benzinga
News headline image
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗
April 23, 2024
Via The Motley Fool
News headline image
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now ↗
April 22, 2024
Via The Motley Fool
News headline image
3 Relatively Safe Growth Stocks You Can Buy and Hold ↗
April 20, 2024
Via The Motley Fool
News headline image
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy? ↗
April 18, 2024
Via The Motley Fool
News headline image
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? ↗
April 15, 2024
Via InvestorPlace
News headline image
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock ↗
April 15, 2024
Via The Motley Fool
News headline image
Could This Stock Be the Next Biotech Buyout? ↗
April 13, 2024
Via The Motley Fool
News headline image
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
April 12, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review ↗
April 12, 2024
Via Investor's Business Daily
Topics Economy
News headline image
Stocks Surge, Goldgasms To Record High After "Adjusted" PPI Sparks Buying Frenzy ↗
April 11, 2024
Via Talk Markets
News headline image
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact ↗
April 11, 2024
Via Benzinga
News headline image
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday? ↗
April 11, 2024
Via Benzinga
Topics Economy
News headline image
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
April 11, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
April 11, 2024
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Near Top of Volume Charts in Thursday Trading
April 11, 2024
Via Investor Brand Network
News headline image
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday ↗
April 11, 2024
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Alpine Immune Sciences, Inc. - Common Stock publicly traded?
Yes, Alpine Immune Sciences, Inc. - Common Stock is publicly traded.
What exchange does Alpine Immune Sciences, Inc. - Common Stock trade on?
Alpine Immune Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alpine Immune Sciences, Inc. - Common Stock?
The ticker symbol for Alpine Immune Sciences, Inc. - Common Stock is ALPN on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap